v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Apr. 30, 2026
Equity [Abstract]  
SCHEDULE OF OPTION ACTIVITY

The table below presents option activity for the six months ended April 30, 2026 and the year ended October 31, 2025:

 

  

Number of

Shares

   Weighted Average Exercise Price per Share   Weighted Average Remaining Contractual Life (in years)  

Aggregate

intrinsic value

 
Balance at October 31, 2024   1,112,923   $10.84    5.64   $1,560,431 
Options exercised   -    -    -    - 
Options granted   -    -    -    - 
Options expired   -    -    -    - 
Options forfeited   -    -    -    - 
Balance at October 31, 2025   1,112,923    10.84    4.64    501,923 
Options exercised   (84,615)   1.30    -    - 
Options granted   -    -    -    - 
Options expired   -    -    -    - 
Options forfeited   -    -    -    - 
Balance at April 30, 2026   1,028,308   $10.84    4.32   $375,000 
SCHEDULE OF COMMON STOCK UNDERLYING OUTSTANDING WARRANTS

A summary of the Company’s common stock underlying its outstanding A and B warrants as of April 30, 2026 and October 31, 2025 is as follows:

 

  

Underlying

Number of
Shares

   Average
Exercise
Price
   Weighted
Average
Life
 
Outstanding – October 31, 2024   261,650   $26.00    1.31 
Warrants A – Granted during the period   -    -    - 
Warrants B – Granted during the period   -    -    - 
Warrants A – Expired during the period   (78,846)   26.00    - 
Warrants B – Expired during the period   -    -    - 
Outstanding – October 31, 2025   182,804    26.00    0.70 
Warrants A – Granted during the period   -    -    - 
Warrants B – Granted during the period   -    -    - 
Warrants A – Expired during the period   -    -    - 
Warrants B – Expired during the period   (33,077)   -    - 
Pre-Funded Warrants – Exercised during the period   -    -    - 
Outstanding – April 30, 2026   149,727   $26.00    0.3 

 

  

Underlying

Number of
Shares

   Average
Exercise
Price
   Weighted
Average
Life
 
Outstanding – October 31, 2024   1,107,500   $0.001    N/A 
Pre-Funded Warrants – Granted during the period   276,000    0.001    N/A 
Pre-Funded Warrants – Exercised during the period   -    -    - 
Pre-Funded Warrants – Expired during the period   -    -    - 
Outstanding – October 31, 2025   1,383,500    0.001    N/A 
Pre-Funded Warrants – Granted during the period   -    -    - 
Pre-Funded Warrants – Exercised during the period   -    -    - 
Pre-Funded Warrants – Expired during the period   -    -    - 
Outstanding – April 30, 2026   1,383,500   $0.001    N/A 
 

 

  

Underlying

Number of
Shares

   Average
Exercise
Price
   Weighted
Average
Life
 
Outstanding – October 31, 2024   -   $-    N/A 
Warrants – Issued during the period   -    -    N/A 
Warrants – Exercised during the period   -    -    - 
Warrants – Expired during the period   -    -    - 
Outstanding – October 31, 2025   -    -    N/A 
Warrants – Issued during the period   28,846    -    16.25 
Warrants – Exercised during the period   -    -    - 
Warrants – Expired during the period   -    -    - 
Outstanding – April 30, 2026   28,846   $-    16.25